Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Anti-tumor Efficacy By Co-delivery Of Doxorubicin And Paclitaxel With Amphiphilic Methoxy PEG-PLGA Copolymer Nanoparticles.

H. Wang, Y. Zhao, Y. Wu, Y. Hu, Kaihui Nan, G. Nie, H. Chen
Published 2011 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
The use of single chemotherapeutic drug has shown some limitations in anti-tumor treatment, such as development of drug resistance, high toxicity and limited regime of clinical uses. The combination of two or more therapeutic drugs is feasible means to overcome the limitations. Co-delivery strategy has been proposed to minimize the amount of each drug and to achieve the synergistic effect for cancer therapies. Attempts have been made to deliver chemotherapeutic drugs simultaneously using drug carriers, such as micelles, liposomes, and inorganic nanoparticles (NPs). Here we reported core-shell NPs that were doubly emulsified from an amphiphilic copolymer methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) (mPEG-PLGA). These NPs offered advantages over other nanocarriers, as they were easy to fabricate by improved double emulsion method, biocompatible, and showed high loading efficacy. More importantly, these NPs could co-deliver hydrophilic doxorubicin (DOX) and hydrophobic paclitaxel (TAX). The drug-loaded NPs possessed a better polydispersity, indicating that they are more readily subject to controlled size distribution. Studies on drug release and cellular uptake of the co-delivery system demonstrated that both drugs were effectively taken up by the cells and released simultaneously. Furthermore, the co-delivery nanocarrier suppressed tumor cells growth more efficiently than the delivery of either DOX or TAX at the same concentrations, indicating a synergistic effect. Moreover, the NPs loading drugs with a DOX/TAX concentration ratio of 2:1 showed the highest anti-tumor activity to three different types of tumor cells. This nanocarrier might have important potential in clinical implications for co-delivery of multiple anti-tumor drugs with different properties.
This paper references
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
Nanoscale double emulsions stabilized by single-component block copolypeptides
Jarrod A. Hanson (2008)
Dielectric behavior of double emulsions with "core-shell droplet" morphology.
R. Pal (2008)
Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer.
Liang Han (2011)
Water soluble inner aqueous phase markers as indicators of the encapsulation properties of water-in-oil-in-water emulsions stabilized with sodium caseinate
Jonathan O' Regan (2009)
Pharmacokinetics of combined doxorubicin and paclitaxel in mice.
D. Gustafson (2005)
Multicomponent therapeutics for networked systems
C. Keith (2005)
Preparation and evaluation of w/o/w type emulsions containing vancomycin.
H. Okochi (2000)
Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
Y. Huang (2000)
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.
A. M. Chen (2009)
Controlled production of monodisperse double emulsions by two-step droplet breakup in microfluidic devices.
Shingo Okushima (2004)
Structural evolution of polymer-stabilized double emulsions.
Wang Ya-fei (2006)
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.
M. Barry (1990)
Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
W. Xiao (2010)
Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment.
H. Qi (2006)
Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.
M. Wani (1971)
Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
N. Wiradharma (2009)
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Y. Li (2001)
Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
T. Tanaka (2004)
Double emulsions: how does release occur?
K. Pays (2002)
Lysosomal destabilization in p53-induced apoptosis
X. Yuan (2002)
From large networks to small molecules.
J. Sharom (2004)
Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity
J. Lehar (2009)
Mechanism of doxorubicin-induced cell death and expression profile analysis
Seongeun Lee (2004)
Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.
N. Tang (2007)
PLGA/polymeric liposome for targeted drug and gene co-delivery.
H. Wang (2010)
Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents.
Qinghua Miao (2010)
Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer
Y. Wang (2006)
The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
Ashlynn L. Z. Lee (2009)
Taxol sensitizes human astrocytoma cells to radiation.
R. Tishler (1992)
Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line.
Y. Liu (1994)
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
W. Kaelin (2005)
Controlled production of mono - disperse double emulsions by two - step droplet breakup in micro fl uidic devices
F Ahmed (2004)
Controlled production of mono - disperse double emulsions by two - step droplet breakup in micro fl uidic devices
F Ahmed (2004)
Nuclear Factor-κB/IκB Signaling Pathway May Contribute to the Mediation of Paclitaxel-induced Apoptosis in Solid Tumor Cells
Yi Huang (2000)
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier.
De-Qun Wu (2009)
Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids
Junping Wang (2005)
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
F. Holmes (1991)
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers.
Y. Li (2001)
Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model.
Y. Gao (2008)
Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.
M. Saad (2008)
Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug.
Fariyal Ahmed (2006)
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
L. Fan (2010)
Preparation of double emulsions by membrane emulsification—a review
S. V. D. Graaf (2005)
Shear Rupturing of Complex Fluids: Application to the Preparation of Quasi-Monodisperse Water-in-Oil-in-Water Double Emulsions
C. Goubault (2001)

This paper is referenced by
Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy
Y. Li (2020)
Preparation and characterization of an injectable thermosensitive hydrogel for simultaneous delivery of paclitaxel and doxorubicin
Mahboubeh Rezazadeh (2018)
Chimeric Nanoparticle: A Platform for Simultaneous Targeting of Phosphatidylinositol-3-Kinase Signaling and Damaging DNA in Cancer Cells.
Sandeep Palvai (2015)
Combination Therapy Using Smac Peptide and Doxorubicin-encapsulated MUC 1-targeted Polymeric Nanoparticles to Sensitize Cancer Cells to Chemotherapy: An in vitro and in vivo Study.
Mojgan Nejabat (2020)
Preparation of Paclitaxel and Etoposide Co-loaded mPEG-PLGA Nanoparticles: an Investigation with Artificial Neural Network
Hassan Maleki (2019)
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
Kamalika Samanta (2019)
Thermo-Responsive Nanocomposite Hydrogels Based on PEG-b-PLGA Diblock Copolymer and Laponite
Tomoki Maeda (2019)
Facilely synthesized pH-responsive fluorescent polymer dots entrapping doped and coupled doxorubicin for nucleus-targeted chemotherapy.
Yixiao Guo (2017)
HER2 Targeted Breast Cancer Therapy with Switchable "Off/On" Multifunctional "Smart" Magnetic Polymer Core-Shell Nanocomposites.
R. Vivek (2016)
Gold nanorod-encapsulated biodegradable polymeric matrix for combined photothermal and chemo-cancer therapy
Chun-Chiao Chuang (2019)
CD 44-targeted PLGA nanoparticles incorporating paclitaxel and FAK siRNA overcome chemoresistance in epithelial ovarian cancer
Yeongseon Byeon (2018)
Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells
J. Zhang (2017)
Development of novel self‐assembled ES‐PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P‐gp inhibition: In vitro and in vivo evaluation
Jia Wang (2017)
Preparation and characterization of Keratin-PEG conjugate-based micelles as a tumor microenvironment-responsive drug delivery system
J. Du (2020)
Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke
Yanxin Dang (2019)
Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
A. Azimi (2018)
Linolenic acid-modified PEG-PCL micelles for curcumin delivery.
Zhimei Song (2014)
Co-delivery of doxorubicin and curcumin by polymeric micelles for improving antitumor efficacy on breast carcinoma
L. Sun (2014)
Smartly Engineered PEGylated Di-Block Nanopolymeric Micelles: Duo Delivery of Isoniazid and Rifampicin Against Mycobacterium tuberculosis
S. Rani (2018)
Materials innovation for co-delivery of diverse therapeutic cargos.
Megan E Godsey (2013)
Combination Drug Delivery Approaches in Metastatic Breast Cancer
J. H. Lee (2012)
Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
W. Song (2014)
A Silver(I)-Estrogen Nanocluster: GSH Sensitivity and Targeting Suppression on HepG2 Cell.
D. Shen (2016)
Nanotechnological strategies for therapeutic targeting of tumor vasculature.
Yanping Ding (2013)
Facile preparation of multifunctional hollow silica nanoparticles and their cancer specific targeting effect.
B. Sahoo (2013)
Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity
W. Sun (2016)
Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
Y. Zhang (2013)
Facile synthesis of multimeric micelles.
Ung Yeol Lee (2012)
A Nano-in-Nano Polymer-Dendrimer Nanoparticle-Based Nanosystem for Controlled Multidrug Delivery.
Zongmin Zhao (2017)
Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
J. Kim (2015)
Nanocarrier mediated combination drug delivery for chemotherapy – A review
R. Pushpalatha (2017)
Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
Fujian Huang (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar